Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning

被引：42

作者：

Martinelli, Vittorio ^{[1
]}

Colombo, Bruno ^{[1
]}

Costa, Gloria Dalla ^{[1
]}

Libera, Dacia Dalla ^{[1
]}

Moiola, Lucia ^{[1
]}

Falini, Andrea ^{[2
]}

Comi, Giancarlo ^{[1
]}

Filippi, Massimo ^{[3
]}

机构：

[1] Hosp San Raffaele, Dept Neurol, Via Olgettina 48, I-20132 Milan, Italy

[2] Hosp San Raffaele, Dept Neuroradiol, Milan, Italy

[3] Ist Sci San Raffaele, Neuroimaging Res Unit, Milan, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 11期

关键词：

DRUG HOLIDAY; INTERRUPTION;

D O I：

10.1177/1352458513492246

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1506 / 1508

页数：3

共 10 条

[1] Observations during an elective interruption of natalizumab treatment: a post-marketing study [J].

Borriello, Giovanna ;

Prosperini, Luca ;

Marinelli, Fabiana ;

Fubelli, Federica ;

Pozzilli, Carlo .

MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (03) :372-375

[2]

Cree B, 2012, NEUROLOGY, V78

[3] Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment [J].

Hellwig, Kerstin ;

Haghikia, Aiden ;

Gold, Ralf .

MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (08) :958-963

[4] Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients [J].

Kerbrat, A. ;

Le Page, E. ;

Leray, E. ;

Anani, T. ;

Coustans, M. ;

Desormeaux, C. ;

Guiziou, C. ;

Kassiotis, P. ;

Lallement, F. ;

Laplaud, D. ;

Diraison, P. ;

Rouhart, F. ;

Sartori, E. ;

Wardi, R. ;

Wiertlewski, S. ;

Edan, G. .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 308 (1-2) :98-102

[5] Natalizumab Drug Holiday in Multiple Sclerosis: Poorly Tolerated [J].

Killestein, Joep ;

Vennegoor, Anke ;

Strijbis, Eva M. ;

Seewann, Alexandra ;

van Oosten, Bob W. ;

Uitdehaag, Bernard M. J. ;

Polman, Chris H. .

ANNALS OF NEUROLOGY, 2010, 68 (03) :392-395

[6] A controlled trial of natalizumab for relapsing multiple sclerosis. [J].

Miller, DH ;

Khan, OA ;

Sheremata, WA ;

Blumhardt, LD ;

Rice, GPA ;

Libonati, MA ;

Willmer-Hulme, AJ ;

Dalton, CM ;

Miszkiel, KA ;

O'Connor, PW .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :15-23

[7] Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy [J].

Miravalle, Augusto ;

Jensen, Rikke ;

Kinkel, Philip .

ARCHIVES OF NEUROLOGY, 2011, 68 (02) :186-191

[8] Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis [J].

O'Connor, P. W. ;

Goodman, A. ;

Kappos, L. ;

Lublin, F. D. ;

Miller, D. H. ;

Polman, C. ;

Rudick, R. A. ;

Aschenbach, W. ;

Lucas, N. .

NEUROLOGY, 2011, 76 (22) :1858-1865

[9] Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients [J].

Vellinga, M. M. ;

Castelijns, J. A. ;

Barkhof, F. ;

Uitdehaag, B. M. J. ;

Polman, C. H. .

NEUROLOGY, 2008, 70 (13) :1150-1151

[10] Natalizumab Dosage Suspension: Are We Helping or Hurting? [J].

West, Timothy W. ;

Cree, Bruce A. C. .

ANNALS OF NEUROLOGY, 2010, 68 (03) :395-399

← 1 →